主要和自身免疫相关的神经髓炎光学谱系障碍之间的临床和免疫学差异:一项回顾性研究
Hung-Cheng Tsai1,2,3, Yi-Syuan Sun1,2,3, Wei-Sheng Chen1,2
1Division of Allergy, Immunology and Rheumatology, Taipei Veterans General Hospital, Taipei, Taiwan.
Lupus science & medicine
|April 14, 2025
概括
在台湾患者中,与自身免疫性疾病 (AD-NMOSD) 相关的光学神经炎谱系障碍显示出独特的实验室发现. 年龄较小和疾病持续时间较长增加了复发风险,与严重后果有关.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
背景情况:
- 神经omyelitis optica光谱障碍 (NMOSD) 是一种罕见的自身免疫性疾病,影响中枢神经系统.
- 关于与自身免疫性疾病 (AD-NMOSD) 相关的NMOSD亚型的数据,特别是在台湾,是有限的.
- 在AD-NMOSD中复发模式和预后因素需要进一步调查.
研究的目的:
- 研究台湾患者的AD-NMOSD的临床特征,复发因素和结果.
- 在同一队列中,将AD-NMOSD与初级NMOSD (p-NMOSD) 进行比较.
- 确定AD-NMOSD中复发和严重后果的特定风险因素.
主要方法:
- 在台北退伍军人总医院2008-2023年间诊断的71例NMOSD病例的回顾性分析.
- 患者的分层是基于复发状态和严重后果的存在.
- 检查临床特征,实验室发现,自身免疫性并发症,成像和治疗方法.
主要成果:
- 37%的NMOSD患者 (26/71) 患有AD-NMOSD. 在这些患者中,
- 与p-NMOSD相比,AD-NMOSD患者表现出不同的实验室概况 (较低的WBC,Hb,血小板,IgG,CRP),但与p-NMOSD相比,复发/连续发生率相似.
- 患AD-NMOSD复发的危险因素包括发病时间小于50年,并发性/较长的SLE持续时间;复发与严重的神经后续相关.
结论:
- 台湾的AD-NMOSD患者表现出独特的实验室特征.
- 年龄较小和自身免疫性疾病持续时间较长是AD-NMOSD中复发的关键预测因素.
- 鉴于治疗限制,个性化管理对于预防复发和严重后果至关重要.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
554
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
554
Myasthenia Gravis: Overview and Treatment
980
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
980


